Solid Organ Transplant: Clinical Trials

23 trials for Solid Organ Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 recruiting, 2 active not recruiting, 2 withdrawn. 8 Not applicable, 3 Phase 1, 3 Phase 2, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 5, Recruiting 2, Unknown 1
Phase 13Completed 1, Not yet recruiting 1, Terminated 1
Phase 23Active not recruiting 2, Completed 1
Phase 43Completed 1, Recruiting 1, Withdrawn 1

Follow Solid Organ Transplant: new trials by email Literature Review of Solid Organ Transplant trials Research Report on Solid Organ Transplant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Rituximab - PTLD, Epstein Barr Virus (EBV) Infection
Phase 1Not yet recruitingJennifer Amengual282026-12-012026-09-17
Feeding the Flame, One Day at a Time: Design and Acceptability of a Serious Game to Support Medication Adherence and Education for Pediatric Solid Organ Transplant Patients
Mystic Wizard - Solid Organ Transplant
Not applicableRecruitingStanford University152026-08-172026-09-28
Use of an Off-the-Shelf Exergame as an In-Bed Gamified Rehabilitation Intervention for Severely Deconditioned Inpatients: A Feasibility Study
Rehabilitation - Bed-ridden Patient, Solid Organ Transplant
Not applicableCompletedAsan Medical Center262024-10-162026-06-09
Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.
Genotyping for CYP3A4 and CYP3A5 genes, Use of NextDose platform, Tacrolimus - Solid Organ Transplant
Phase 4RecruitingMurdoch Childrens Research Institute452024-08-052026-02-25
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
Fluzone High-Dose - 2 doses, Fluzone High-Dose - 1 dose of HD - Solid Organ Transplant
Not applicableCompletedUniversity of Minnesota742023-09-112025-07-15
iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
iParent2Parent Program - Solid Organ Transplant
Not applicableRecruitingThe Hospital for Sick Children552023-08-012025-05-16
REmote moBile Outpatient mOnitoring in Transplant 2.0
Active communication through Reboot application, Generic communication through Reboot application - Solid Organ Transplant, Heart Transplant
Not applicableUnknownUniversity Health Network, Toronto4002023-04-012022-11-16
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Hematopoietic Cell Transplant, Solid Organ Transplant
RecruitingArkansas Children's Hospital Research Institute20002022-12-132025-10-02
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Cancer, Hematopoietic System--Cancer
CompletedSt. Jude Children's Research Hospital212022-06-292026-04-15
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
Ruxolitinib - Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati132021-10-272024-01-16
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Three doses of SARS-CoV-2 BNT162b2 vaccine (observational), Two doses of CoronaVac and one dose of BNT162b2 SARS-CoV-2 vaccine (observational) - COVID-19, SARS-CoV-2 Infection
CompletedPontificia Universidad Catolica de Chile1472021-10-062022-01-12
iPeer2Peer Pediatric Thoracic Transplantation
iPeer2Peer Support Mentorship Program - Solid Organ Transplant
Not applicableCompletedThe Hospital for Sick Children342021-05-202023-12-18
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19 - Autoimmune or Autoinflammatory Diseases, HIV
Not applicableCompletedAssistance Publique - Hôpitaux de Paris3772021-04-162023-02-06
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
High Dose Quadrivalent Inactivated Influenza Vaccine, Standard Dose Quadrivalent Inactivated Influenza Vaccine - Immunization; Infection, Transplantation Infection
Phase 2Active not recruitingVanderbilt University Medical Center3962021-01-112026-10-02
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
Viral Specific T-cells (VSTs) - Solid Organ Transplant, Viral Infection
Phase 2Active not recruitingChildren's Hospital Medical Center, Cincinnati422020-08-182026-10-22
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
CMV specific T-cells - Cytomegalovirus Infections, Solid Organ Transplant
Phase 1TerminatedUniversity of Wisconsin, Madison22019-09-272024-02-20
Early Flu Shots in SOT
standard of care influenza vaccine - Influenza, Solid Organ Transplant
WithdrawnUniversity Health Network, Toronto2019-05-072020-10-20
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
fidaxomicin - Clostridium Difficile Infection, Solid Organ Transplant
Phase 4WithdrawnUniversity of Colorado, Denver2018-06-012018-08-29
Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients
Lamivudine 300 MG, Abacavir 600 MG, Dolutegravir 50 mg - HIV-1-infection, Solid Organ Transplant
Phase 4CompletedFundacion Clinic per a la Recerca Biomédica192018-04-132025-09-30
Discharge to Home and Chronic Illness Care Pilot
myFAMI iPad application - Solid Organ Transplant
Not applicableCompletedMedical College of Wisconsin202014-06-012019-03-07

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

COVID-19 (2)  ·  Epstein-Barr Virus Infections (2)  ·  Infections (2)  ·  Influenza, Human (2)  ·  Neoplasms (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Clostridium Infections (1)  ·  Critical Illness (1)  ·  Cytomegalovirus Infections (1)  ·  Fusariosis (1)  ·  Hematologic Neoplasms (1)  ·  Multiple Sclerosis (1)  ·  Virus Diseases (1)

Broader conditions

Infections (8)  ·  Virus Diseases (7)  ·  Respiratory Tract Diseases (5)  ·  RNA Virus Infections (4)  ·  Respiratory Tract Infections (4)  ·  DNA Virus Infections (3)  ·  Herpesviridae Infections (3)  ·  Lung Diseases (3)  ·  Bacterial Infections and Mycoses (2)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Immune System Diseases (2)  ·  Nidovirales Infections (2)  ·  Orthomyxoviridae Infections (2)  ·  Pneumonia (2)

Interventions

Influenza Vaccines (2)  ·  Rituximab (2)  ·  Blood Specimen Collection (1)  ·  Bortezomib (1)  ·  Emtricitabine (1)  ·  Fidaxomicin (1)  ·  Fluzone High-Dose (1)  ·  Genotype (1)  ·  Lamivudine (1)  ·  Rehabilitation (1)  ·  Tablets (1)  ·  Tacrolimus (1)  ·  Tenofovir (1)  ·  abacavir (1)  ·  dolutegravir (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (2)  ·  Medical College of Wisconsin (2)  ·  The Hospital for Sick Children (2)  ·  University Health Network, Toronto (2)  ·  Arkansas Children's Hospital Research Institute (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Fundacion Clinic per a la Recerca Biomédica (1)  ·  Jennifer Amengual (1)  ·  Massachusetts General Hospital (1)  ·  Murdoch Childrens Research Institute (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  St. Jude Children's Research Hospital (1)  ·  Stanford University (1)  ·  University of Colorado, Denver (1)

Countries

United States (12)  ·  Canada (3)  ·  Australia (1)  ·  Chile (1)  ·  France (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Adarsh Bhimraj, MD (1)  ·  David Metz, MBBS, PhD (1)  ·  Deepali Kumar, MD (1)  ·  Diego Hijano, MD (1)  ·  Gabriela Maron, MD (1)  ·  Heather Ross, MD (1)  ·  Jacques Galipeau, MD (1)  ·  Jennifer Amengual, MD (1)  ·  Jeremy Abramson, MD (1)  ·  Kelly E Schoeppler, PharmD (1)  ·  Lauren Fontana, MD (1)  ·  Pooja Khandelwal, MD (1)  ·  Rachel Conyers (1)  ·  Samantha J Anthony, PhD (1)

Results publications

PMID 34528885, PMID 36185969, PMID 37310391, PMID 42614627

NIH funding

2017 (1), R01AI159684 (1)